Jazz Pharmaceuticals reports fiscal Q3 profit
Jazz Pharmaceuticals reported fiscal 2026 third-quarter profit attributable to shareholders, up 100.45% year over year.
Related stories
Anthropic: Google, Nvidia, AMD, Broadcom, Micron, Microsoft And TSMC To Invest $26B Via Private Placement At IPO Price
Anthropic Told Bankers The IPO Filing They Received Was Incorrect And Will Provide Updated Figures
L impact | EQUITY | Nov 10, 2026, 01:51 AM UTC
Suzhou Denglin Technology Shares Fall in Hong Kong Trading Debut
L impact | EQUITY | Nov 10, 2026, 01:50 AM UTC
Lindian Secures Binding Offtake for 30,000 Tonnes
Lindian secured a binding offtake term sheet for 10,000 dmt for Stage 1 and 20,000 dmt per annum for Stage 2. The company says Stage 1 capacity is fully allocated and more than 45,
M impact | EQUITY | Nov 10, 2026, 01:47 AM UTC
Lindian Secures Binding 30,000-Tonne Monazite Concentrate Offtake
Lindian Resources says its Singapore subsidiary executed a binding offtake term sheet ahead of December production.
M impact | EQUITY | Nov 10, 2026, 01:47 AM UTC
Malaysia’s KLCI reverses gains, falls 0.8% to 1,604.33
M impact | EQUITY | Nov 10, 2026, 01:42 AM UTC
Red Hill Minerals Agrees Proposed Divestment of Pannawonica Iron Project
Red Hill Minerals entered into a heads of agreement with Arrow Minerals for the proposed divestment of its Pannawonica Iron Project.
L impact | EQUITY | Nov 10, 2026, 01:39 AM UTC